Insights from the 2016 IHRSA Health Club Consumer Report

IHRSA, with analysis and insights provided by ClubIntel, recently published the 2016 Health Club Consumer Report (can be acquired at ihrsa.org/research-reports). The 2016 Health Club Consumer Report, like its predecessors, delves into the attitudes and behaviors of health/fitness facility consumers, seeking to understand the impact these practices might have on how club and studio operators shape their business in the future. In 1919, Marcel Proust, in his book “A l’ombre des jeunes filles en fleurs” was quoted as saying, “What we call our future is the shadow that our past projects in front of us”. Well, in the case of the health club industry, the consumer behaviors brought forth in this year’s report portray a vivid story of the recent past and present, providing an excellent GPS for operators to follow in 2017 and beyond.

Spotlight

OneOme

Oneome’s rightmed comprehensive test and supporting tools help providers make more personalized prescription decisions for their patients, which may result in more effective medications and fewer side effects. the rightmed test is a pharmacogenomic test also called a medication response test that analyzes a person's dna to predict how he or she is likely to respond to a medication. the test covers hundreds of medications used across psychiatry, oncology, pain management, cardiology, and many other areas.

OTHER WHITEPAPERS
news image

Healthcare Provider Network Saves $5 Million and Acquires In-House Archiving Skills

whitePaper | September 7, 2021

Numerous acquisitions and technology upgrades put many applications and associated data stores into a legacy state for a large, multi-state integrated healthcare provider network. The organization turned to Flatirons Digital Innovations (FDI) to help decommission those applications deemed most critical to save costs and eliminate risks associated with running aging legacy systems, while ensuring ongoing access to complete patient data.

Read More
news image

Personalizing Radiotherapy in Oncology: The Evolution of Treatment

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.

Read More
news image

Unlocking intelligence for better experiences, better insights, and better care

whitePaper | September 19, 2022

The volume of data and its pace of accumulation is only increasing. Almost every day, up to 2.5 quintillion bytes of data is created by humans, edge, IOT devices, and machines, according to Domo.

Read More
news image

The Impact of Ransomware on Healthcare During COVID-19 and Beyond

whitePaper | November 17, 2021

The pandemic hit the healthcare industry hard, but it also weakened the cybersecurity defenses of most providers, making them far more vulnerable to threats such as ransomware. This report, covered across national news, is considered the most significant actionable cybersecurity research over the past several years because it also documents the severe impact on patient care. This executive summary includes critical areas that providers can address starting today.

Read More
news image

2022 Global Predictions Whitepaper

whitePaper | January 14, 2022

In the past year, more than nine billion doses of coronavirus vaccines have been administered, in at least 197 countries worldwide according to the BBC and Oxford University.

Read More
news image

Delivering new treatments faster with a data flow ecosystem

whitePaper | February 14, 2023

Capturing and combing through various data sets can be overwhelming, especially in today’s clinical trial environment. An end-to-end data environment creates new opportunities.

Read More

Spotlight

OneOme

Oneome’s rightmed comprehensive test and supporting tools help providers make more personalized prescription decisions for their patients, which may result in more effective medications and fewer side effects. the rightmed test is a pharmacogenomic test also called a medication response test that analyzes a person's dna to predict how he or she is likely to respond to a medication. the test covers hundreds of medications used across psychiatry, oncology, pain management, cardiology, and many other areas.

Events